You might be wondering who even asked for another golf league. The truth is, no one really did. But here we are, with a new virtual golf competition hitting our screens. This isn't your typical golf event—it's more like a video game come to life. The league, called TGL, is using top golfers and fanc
Imagine diving into the future of mental health and wellness. Psychedelics, once shunned, are now gaining renewed interest. Why? Scientists and the public are waking up to their potential. Research shows substances like psilocybin (magic mushrooms) and MDMA can rewire the brain, helping with conditi
In a big change, Meta is saying goodbye to fact checkers on Facebook and Instagram. Instead, they're bringing in something called community notes. These are like labels that users can add to posts, pointing out if something might be wrong. This shift comes as Meta's top bosses seem to be moving more
Ever thought why some days stand out? Well, January 9, 2025, is one of those days. This day is dedicated to remembering the 39th U. S. President, James Earl Carter Jr. President Biden has declared it a National Day of Mourning. So, if you've got a naturalization ceremony, interview, or appointment p
Imagine if you could harness the power of light in a tiny particle. Well, researchers have done just that by mixing together a special set of chemicals. One of the key ingredients is a compound called bis-naphthylacrylonitrile derivative (BND). This isn't your average chemical; it's really good at g
Muscle wasting is a serious issue as we age or fall ill. Sarcopenia hits elderly folks, making their muscles shrink faster. Cachexia is worse, often tied to illnesses like cancer. Both have different roots, but they share some molecular tactics. Figuring out these differences and similarities is cru
Ever imagined a place where science and humanities meet to discuss something unusual? Three recent studies have shown that psychedelics might improve sexual well-being. But scientists need to explore how culture and history influence our views on sexuality. The field of psychedelics hasn't paid much
Imagine you're battling advanced biliary tract cancer (ABTC), and your doctors suggest a mix of drugs: nivolumab, modified gemcitabine, and S-1. This combo showed promise in a past trial, but PD-L1 levels didn't tell us much about how well it would work. So, scientists looked at another marker, LAG-
You might not think about it, but the time of day you get your cancer treatment could make a difference. Scientists have been looking into how our body's internal clock, called the circadian rhythm, affects how well cancer drugs work. One type of drug, called immune checkpoint inhibitors (ICIs), has
Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the
